TriangleMRIdian Radiation Treatment Unit (NCT03936478)
MRIdian Radiation Treatment Unit trial for Breast Cancer (NCT03936478). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for women aged forty or older after lumpectomy for early breast cancers or ductal carcinoma in situ. Tumor size, margins, and pathology must meet study limits. BRCA1 or BRCA2 mutations exclude entry.
The idea: MRI-guided radiation targets the lumpectomy cavity in three sessions of 8.2 gray, with at least forty hours between sessions. Researchers assess breast appearance and tissue damage. The enrollment stage depends on safety results from the first ten patients.
This phase 2 study plans 30 patients. Bethany Anderson leads at Wisconsin, Madison, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.